Anti-human PD1 monoclonal antibody and application thereof
A monoclonal antibody, antibody technology, applied in the direction of antibody, anti-animal/human immunoglobulin, application, etc., can solve the problems of lack of MYPPY, inability to bind B7-1 and B7-2, etc., to achieve the effect of novel sequence
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0039] Example 1 Obtaining specific anti-PD1 mouse monoclonal antibodies by fusion hybridoma technology
[0040] 1.1 Animal immunity
[0041] The mice were immunized according to the general method in the literature (E Harlow, D. Lane, Antibody: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1998). The immunogen is a recombinant human PD1 (amino acid range Leu 25-Gln 167) protein (Acrobiosystems, Cat#PD1-H5257) with a human IgG1Fc tag at the C-terminus. The recombinant human PD1 protein with his s tag (Sino biological inc., cat#10377-H08H) was used as the detection antigen for serum titer determination and hybridoma screening. Briefly, take out an appropriate amount of Freund's adjuvant into a 1.5ml EP tube and mix it with a shaker. Prepare the antigen protein solution with PBS. Mix the adjuvant and protein antigen solution according to the required amount, push each other through a syringe to fully emulsify the antigen to form a stable water...
Example Embodiment
[0047] Example 2 In vitro analysis method for determining the functional activity of PD1 monoclonal antibody
[0048] 2.1 Determination of antibody binding ability based on capture ELSIA
[0049] Prepare goat anti-mouse IgG Fcr-specific secondary antibody (Jackson Immuno Research, #115-006-071) with 1xPBS to make the final concentration 2μg / ml, add 100μl / well to 96-well microplate, 4 degrees Coated overnight. The next day, the plate was washed 4 times with a PBS solution containing 0.05% Tween 20 (ie 1xPBST), and 200 μl / well of 5% skimmed milk powder in PBST solution was added and placed at 37°C for 2 hours. Wash the plate again, add 100μl / well of diluted antibody solution or hybridoma supernatant, incubate at 37°C for 40 minutes, and then wash the plate 4 times. Add the prepared 60nM biotin-labeled human PD1-Fc protein solution (in 2.5% skimmed milk powder in PBST) at 100 μl / well, incubate at 37°C for 40 minutes, and then wash the plate 4 times. Add 1:10000 diluted horseradish ...
Example Embodiment
[0059] Example 3 Binding activity of anti-PD1 mouse monoclonal antibody
[0060] According to the analysis method described in Example 2.1, the binding activity of PD1 mouse monoclonal antibody was evaluated and summarized in Table 2 below. Reference antibody As a control, it is an existing commercialized anti-human PD1 monoclonal antibody. It can be seen from Table 2 that the binding activity of the anti-human PD1 monoclonal antibody of the present invention to human PD1 antigen is equivalent to that of the reference antibody.
[0061] Table 2 PD1 antibody binding activity
[0062]
[0063]
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap